TVARDI THERAPEUTICS, INC. Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
TVARDI THERAPEUTICS, INC. (TVRD) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of $319.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2020-11-09
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2020-09-30 was -$206.00K.
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2020-06-30 was $763.00K, a 729.35% increase year-over-year.
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2020-03-31 was -$238.00K, a 227.27% decline year-over-year.
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2019-12-31 was $17.00K.
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2019 was $284.00K.
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2018 was -$49.00K.
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2017 was -$68.00K, a 211.48% decline from fiscal 2016.
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2016 was $61.00K.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month |
|---|---|---|---|---|
| 2020-09-30 | -$206.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $557.00K derived: sum of 2 quarters · filed 2020-11-09 | $319.00K 10-Q · filed 2020-11-09 | $336.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | $763.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $525.00K 10-Q · filed 2020-08-10 | $542.00K derived: sum of 3 quarters · filed 2020-08-10 | $530.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-03-31 | -$238.00K 10-Q · filed 2020-05-11 | -$221.00K derived: sum of 2 quarters · filed 2020-05-11 | -$233.00K derived: sum of 3 quarters · filed 2020-11-09 | -$141.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $5.00K derived: sum of 2 quarters · filed 2020-11-09 | $97.00K derived: sum of 3 quarters · filed 2020-11-09 | $284.00K 10-K · filed 2020-02-27 |
| 2019-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $80.00K derived: sum of 2 quarters · filed 2020-11-09 | $267.00K 10-Q · filed 2020-11-09 | $167.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $279.00K 10-Q · filed 2020-08-10 | $179.00K derived: sum of 3 quarters · filed 2020-08-10 | $232.00K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $187.00K 10-Q · filed 2020-05-11 | $87.00K derived: sum of 2 quarters · filed 2020-05-11 | $140.00K derived: sum of 3 quarters · filed 2020-05-11 | $197.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$47.00K derived: sum of 2 quarters · filed 2020-02-27 | $10.00K derived: sum of 3 quarters · filed 2020-02-27 | -$49.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $110.00K derived: sum of 2 quarters · filed 2019-11-05 | $51.00K 10-Q · filed 2019-11-05 | -$58.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$2.00K 10-Q · filed 2019-08-07 | -$111.00K derived: sum of 3 quarters · filed 2020-02-27 | -$57.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$59.00K 10-Q · filed 2019-05-07 | -$168.00K derived: sum of 2 quarters · filed 2020-02-27 | -$114.00K derived: sum of 3 quarters · filed 2020-02-27 | -$151.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$55.00K derived: sum of 2 quarters · filed 2020-02-27 | -$92.00K derived: sum of 3 quarters · filed 2020-02-27 | -$68.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $17.00K derived: sum of 2 quarters · filed 2018-11-06 | $41.00K 10-Q · filed 2018-11-06 | $35.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | -$37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$13.00K 10-Q · filed 2018-08-07 | -$19.00K derived: sum of 3 quarters · filed 2019-03-12 | -$28.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $24.00K 10-Q · filed 2018-05-09 | $18.00K derived: sum of 2 quarters · filed 2019-03-12 | $9.00K derived: sum of 3 quarters · filed 2019-03-12 | $46.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$15.00K derived: sum of 2 quarters · filed 2019-03-12 | $22.00K derived: sum of 3 quarters · filed 2019-03-12 | $61.00K 10-K · filed 2019-03-12 |
| 2016-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $28.00K derived: sum of 2 quarters · filed 2017-11-02 | $67.00K 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $76.00K 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $39.00K 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | -$35.00K 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |